New Men B immunisation advice

Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice:

Men B immunisation programme

Following recent media coverage about the death of a young girl from invasive meningococcal disease caused by Men B, many GP practices have had queries from parents about the availability of Men B immunisation. 

This information is taken from Public Health England publications and the GOV.UK website (see below for details).

What is the national policy for Men B immunisation?

The Men B immunisation programme started on 1 September 2015 for babies aged 2 months, ie, babies born on or after 1 July 2015.  There was a limited catch-up programme for babies born on or after 1 May 2015.  The routine schedule is for immunisation to be given at 2 and 4 months with the primaries, with a booster at 12 months.

Can I vaccinate children born before 1 May 2015 if parents request it? 

No. The national stock of Bexsero® should only be used to vaccinate children who are eligible for NHS vaccination.

Can I vaccinate children born on or after 1 May 2015 who have not yet been vaccinated?

Yes.  All children in the eligible cohort (ie, born on or after 1 May 2015) remain eligible for Men B immunisation until the age of two years. When Bexsero® has not been given as part of a primary course, give two doses at least two months apart. Those children who have received one dose before their first birthday only require one more dose. Please see the MenB PGD for more information.

If parents ask to pay for Men B immunisation for their children, what should I tell them?

GPs should not charge their own patients (ie, those registered at their practice) a private fee for the vaccine.

Parents seeking the vaccine privately should be made aware that they will be liable for the full costs of the vaccine and any additional administration charges that the private provider may apply. We understand that GSK has supply constraints on the Bexsero vaccine for the private market. Practices must not use centrally-procured stock for the national programme to vaccinate private patients or any patients outside the eligible cohort (other than those at high risk as defined in the green book).

Further information

Last updated : 16 Mar 2016

 

The M Word issue 6 - Dr Michelle Drage's latest personal briefing for practices on NHS reforms (16 Dec 2011)

I have 3 updates for you:   The Health and Social Care Bill, 1 year on GP Primary Medical...
Read more »

The M Word issue 5 - Dr Michelle Drage's latest personal briefing for practices on NHS reforms (10 Oct 2011)

  Here's the latest update on what has and what has not been going on over the last few weeks, and what is likely to happen over the Autumn. I...
Read more »

The M Word issue 4 - Dr Drage's briefing on the NHS reforms (15 Jun 2011)

The Day After...   The Politics The Real World Michelle’s 3 step guide (definitely not a toolkit) to QIPP and GRIP   Dr Michelle Drage FRCGPCEO Londonwide...
Read more »

The M Word issue 3 - Dr Michelle Drage's briefing on NHS reforms (07 Jun 2011)

I thought I’d share three of my more serious thoughts to do with Providing General Practice and NOT commissioning (mostly!)   The new transitional management landscape in London Our...
Read more »

GPC news June 2011 (01 Jun 2011)

Download latest edition of GPC news here.
Read more »

The M Word issue 2 - Dr Michelle Drage's personal briefing for practices on NHS reforms (14 Apr 2011)

In issue 1 I set out to make some sense of the language and jargon of the new NHS world and give you some not-so-subliminal messages about what we...
Read more »

The M Word issue 1 (10 Apr 2011)

Dr Michelle Drage's personal briefing for practices on NHS reforms. This is the first in my personal series of briefings which will provide commentary and updates on key issues facing...
Read more »

GPC news October 2009 (01 Oct 2009)

Download the latest edition of GPC news here.
Read more »
« Previous Page